Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Ligand Pharmaceuticals Incorporated - Common Stock (NQ:LGND)

318.54 -1.01 (-0.32%)

Streaming Delayed Price Updated: 9:50 AM EDT, Jul 6, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	38,687
Open	319.94
Bid (Size)	313.74 (100)
Ask (Size)	320.60 (100)
Prev. Close	319.55
Today's Range	316.97 - 321.89
52wk Range	112.83 - 320.99
Shares Outstanding	16,676,532
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Ligand Pharmaceuticals Director Unloads 2,501 Shares — Should You Be Concerned? ↗

June 14, 2026

This biotech innovator, known for its royalty-driven model, reported a notable insider sale amid a period of strong share price gains.

Via The Motley Fool

A Ligand Pharmaceuticals (LGND) Insider Sold 5,000 Shares for $1.1 Million ↗

June 07, 2026

Biotech royalty player Ligand Pharmaceuticals reported a notable insider sale following a year of strong stock performance.

Via The Motley Fool

Performance

YTD	+67.6%	+67.6%
1 Month	+34.4%	+34.4%
3 Month	+56.4%	+56.4%
6 Month	+65.9%	+65.9%
1 Year	+180.0%	+180.0%

More News

Wealth Manager Sells $7 Million of Establishment Labs After Massive Gains. Is This Medical Device Stock a Buy? ↗

May 30, 2026

Via The Motley Fool

Ligand Pharmaceuticals (NASDAQ:LGND) Shares Fall on Q1 Revenue and EPS Miss ↗

May 07, 2026

Via Chartmill

Ligand Pharmaceuticals (NASDAQ:LGND) Passes Minervini Trend Template and Growth Screen ↗

April 01, 2026

Via Chartmill

Ligand Pharmaceuticals (NASDAQ:LGND) Beats Q4 Estimates and Reaffirms 2026 Guidance ↗

February 26, 2026

Via Chartmill

OneSpaWorld Posted Record Revenue for Last Quarter. Why Did a Fund Exit a $21.5 Million Stake? ↗

May 29, 2026

Via The Motley Fool

Is Genpact Stock a Buy After Hedge Fund Rice Hall James Raised Its Stake by $14 Million? ↗

May 19, 2026

Via The Motley Fool

Is WaterBridge Stock a Buy After Ranger Investment Raised Its Stake by 345,000 Shares? ↗

May 16, 2026

Via The Motley Fool

Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates

May 12, 2026

From Orchestra BioMed Holdings, Inc.

Via GlobeNewswire

Ligand (LGND) Q1 2026 Earnings Call Transcript ↗

May 12, 2026

Via The Motley Fool

Ligand Pharmaceuticals Q1 Earnings Call Highlights ↗

May 08, 2026

Via MarketBeat

Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement

May 06, 2026

From Orchestra BioMed Holdings, Inc.

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX), Soleno Therapeutics, Inc. (Nasdaq – SLNO)

May 05, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Villere St Denis Liquidates $18 Million Euronet Worldwide Stake, According to Recent SEC Filing ↗

May 04, 2026

Via The Motley Fool

Villere St Denis Dumps 134,000 Tidewater (TDW) Shares Worth $9.3 Million ↗

May 02, 2026

Via The Motley Fool

April 27, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator

April 27, 2026

From XOMA Royalty Corporation

Via GlobeNewswire

CLO Sells LGND 5,000 Shares for $1.0 Million ↗

March 30, 2026

Via The Motley Fool

Ligand Pharma CFO Sells $688K in Stock as Shares Surge 80% This Past Year. Here's What to Know ↗

March 27, 2026

Via The Motley Fool

Rice Hall James Buys QuidelOrtho Stock ↗

March 09, 2026

Via The Motley Fool

Rice Hall James Buys Stride Stock ↗

March 09, 2026

Via The Motley Fool

Ligand Pharma (LGND) Earnings Call Transcript ↗

February 26, 2026

Via The Motley Fool

The Great Rotation: Small-Caps Break the Mega-Cap Monopoly in Early 2026

February 23, 2026

Via MarketMinute

This $38.8 Million Vicor Bet Is Getting Bigger Amid a 200% Stock Surge ↗

February 17, 2026

Via The Motley Fool

Frequently Asked Questions

Is Ligand Pharmaceuticals Incorporated - Common Stock publicly traded?

Yes, Ligand Pharmaceuticals Incorporated - Common Stock is publicly traded.

What exchange does Ligand Pharmaceuticals Incorporated - Common Stock trade on?

Ligand Pharmaceuticals Incorporated - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Ligand Pharmaceuticals Incorporated - Common Stock?

The ticker symbol for Ligand Pharmaceuticals Incorporated - Common Stock is LGND on the Nasdaq Stock Market

What is the current price of Ligand Pharmaceuticals Incorporated - Common Stock?

The current price of Ligand Pharmaceuticals Incorporated - Common Stock is 318.54

When was Ligand Pharmaceuticals Incorporated - Common Stock last traded?

The last trade of Ligand Pharmaceuticals Incorporated - Common Stock was at 07/06/26 09:50 AM ET

What is the market capitalization of Ligand Pharmaceuticals Incorporated - Common Stock?

The market capitalization of Ligand Pharmaceuticals Incorporated - Common Stock is 5.31B

How many shares of Ligand Pharmaceuticals Incorporated - Common Stock are outstanding?

Ligand Pharmaceuticals Incorporated - Common Stock has 5B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.